510(k) K013662

MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS by Quantimetrix Corp. — Product Code JHO

K013662 is an FDA 510(k) premarket notification submitted by Quantimetrix Corp. for the device "MODIFICATION TO LIPOPRINT SYSTEM, LDL SUBFRACTIONS". The FDA issued a decision of Substantially Equivalent on March 8, 2002. The device falls under product code JHO (Electrophoretic Separation, Lipoproteins), a Class I device regulated under 21 CFR 862.1475. Quantimetrix Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
March 8, 2002
Date Received
November 6, 2001
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Electrophoretic Separation, Lipoproteins
Device Class
Class I
Regulation Number
862.1475
Review Panel
CH
Submission Type